In the era of biologics, although several meta-analyses have shown the efficacy of anti-TNF biologics in significantly reducing hospitalization rates by approximately 50% and surgery rates by 33–77% in IBD patients, [30] it is essential to recognize the potential adverse effects of these medications in terms of triggering opportunistic infections. Here, TNF is linked to inflammatory bowel disease.